Apoptotic and anti‐Warburg effect of Morusin via ROS mediated inhibition of FOXM1/c‐Myc signaling in prostate cancer cells

Author:

Koo Ja Il1,Sim Deok Yong1,Lee Hyo‐Jung1,Ahn Chi‐Hoon1,Park JiEon1,Park Su‐Yeon1,Lee Dain1,Shim Bum‐Sang1,Kim Bonglee1,Kim Sung‐Hoon1ORCID

Affiliation:

1. College of Korean Medicine Kyung Hee University Seoul Republic of Korea

Abstract

AbstractThough Morusin is known to induce apoptotic, antiprolifertaive, and autophagic effects through several signaling pathways, the underlying molecular mechanisms of Morusin still remain unclear until now. To elucidate antitumor mechanism of Morusin, cytotoxicity assay, cell cycle analysis, Western blotting, TUNEL assay, RNA interference, immunofluorescense, immunoprecipitation, reactive oxygen species (ROS) measurement, and inhibitor study were applied in this study. Morusin enhanced cytotoxicity, increased the number of TUNEL positive cells, sub‐G1 population and induced the cleavages of PARP and caspase3, attenuated the expression of HK2, PKM2, LDH, c‐Myc, and Forkhead Box M1 (FOXM1) along with the reduction of glucose, lactate, and ATP in DU145 and PC3 cells. Furthermore, Morusin disrupted the binding of c‐Myc and FOXM1 in PC‐3 cells, which was supported by String and cBioportal database. Notably, Morusin induced c‐Myc degradation mediated by FBW7 and suppressed c‐Myc stability in PC3 cells exposed to MG132 and cycloheximide. Also, Morusin generated ROS, while NAC disrupted the capacity of Morusin to reduce the expression of FOXM1, c‐Myc, pro‐PARP, and pro‐caspase3 in PC‐3 cells. Taken together, these findings provide scientific evidence that ROS mediated inhibition of FOXM1/c‐Myc signaling axis plays a critical role in Morusin induced apoptotic and anti‐Warburg effect in prostate cancer cells. Our findings support scientific evidence that ROS mediated inhibition of FOXM1/c‐Myc signaling axis is critically involved in apoptotic and anti‐Warburg effect of Morusin in prostate cancer cells.

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3